» Articles » PMID: 34284789

Modulation and Bioinformatics Screening of Hepatic MRNA-lncRNAs (HML) Network Associated with Insulin Resistance in Prediabetic and Exercised Mice

Overview
Publisher Biomed Central
Date 2021 Jul 21
PMID 34284789
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Insulin resistance is associated with prediabetes and further progression to type 2 diabetes mellitus (T2DM). This study aims to investigate novel hepatic lncRNAs associated with key genes in insulin resistance in prediabetes.

Methods: In the bioinformatics phase, we have collected screened a pool of lncRNAs and mRNAs according to their potential association to prediabetic condition. We performed pathway analysis of mRNAs, using DAVID tool based on KEGG repository data. Then, we used Python programming language to get a subset of lncRNAs located in 50 kb proximity with high-fat (HF)-responsive mRNAs. In the experimental phase, prediabetic mice model was established by the treatment of HF diets for 12 weeks. After this treatment, HF-fed animals were divided into two groups of endurance exercised or sedentary, both continuing on the HF diet for 8 weeks. Besides, a group of diabetic mice was treated using a HF diet for 8 weeks followed by injection with STZ solution and then a HF diet for another 4 weeks.

Results: We found three genes having paired lncRNAs annotated in insulin resistance pathway. Their hepatic expression levels were altered in prediabetic condition as upregulation of Srebf1 was associated with GM38501, upregulation of Pck1 was associated with Ctcflos and GM36691, downregulation of Cpt1b was associated with GM44502. All of these expression patterns were replicated in diabetic mice, correlated positively with their predicted lncRNAs. Interestingly, exercise reversed their expression patterns.

Conclusions: We suggest that the expression pattern of the hepatic mRNA-lncRNA (HML) network in prediabetic state undergoes similar modification to that of diabetes.

Citing Articles

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.

Devasia A, Ramasamy A, Leo C Int J Mol Sci. 2025; 26(4).

PMID: 40004240 PMC: 11855529. DOI: 10.3390/ijms26041778.


Exercise may improve lung immunity after surgical stress: Evidence from a nephrectomy model via a bioinformatic analysis.

Wu M, Luo H, Chang Y, Yu C, Sung W PLoS One. 2024; 19(6):e0303334.

PMID: 38848417 PMC: 11161109. DOI: 10.1371/journal.pone.0303334.


Identification of ferroptosis-related genes as potential diagnostic biomarkers for diabetic nephropathy based on bioinformatics.

Guo B, Li M, Wu P, Chen Y Front Mol Biosci. 2023; 10:1183530.

PMID: 37593129 PMC: 10428009. DOI: 10.3389/fmolb.2023.1183530.


Co-expression analysis of lncRNA and mRNA identifies potential adipogenesis regulatory non-coding RNAs involved in the transgenerational effects of tributyltin.

Lopes M, Felix J, Scaramele N, Almeida M, Furlan A, Troiano J PLoS One. 2023; 18(2):e0281240.

PMID: 36735680 PMC: 10045570. DOI: 10.1371/journal.pone.0281240.


Long Noncoding RNAs in the Pathogenesis of Insulin Resistance.

Yang W, Lyu Y, Xiang R, Yang J Int J Mol Sci. 2022; 23(24).

PMID: 36555704 PMC: 9785789. DOI: 10.3390/ijms232416054.


References
1.
Liu Q, Bengmark S, Qu S . The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis. 2010; 9:42. PMC: 2873482. DOI: 10.1186/1476-511X-9-42. View

2.
Zhang D, Qin H, Leng Y, Li X, Zhang L, Bai D . LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF. Exp Ther Med. 2018; 16(3):2337-2342. PMC: 6122501. DOI: 10.3892/etm.2018.6451. View

3.
Zhu X, Wu Y, Zhou J, Kang D . Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression. Biochem Biophys Res Commun. 2015; 469(2):319-25. DOI: 10.1016/j.bbrc.2015.11.048. View

4.
Han H, Kang G, Kim J, Choi B, Koo S . Regulation of glucose metabolism from a liver-centric perspective. Exp Mol Med. 2016; 48:e218. PMC: 4892876. DOI: 10.1038/emm.2015.122. View

5.
Johnson A, Olefsky J . The origins and drivers of insulin resistance. Cell. 2013; 152(4):673-84. DOI: 10.1016/j.cell.2013.01.041. View